PlainPill

BPC-157 vs GHK-Cu for pain & inflammation

Short answer: For pain & inflammation, users rate them about the same: 86% report improvement with BPC-157 (485 reports) and 90% with GHK-Cu (31 reports).

BPC-157 has 0 meta-analyses and 0 randomized trials on PubMed; GHK-Cu has 0 and 1.

Based on 1,613 reports about BPC-157 and 496 about GHK-Cu. Not medical advice.

BPC-157
Peptide
GHK-Cu
Peptide
Users say it helped54%helped919 reports · high confidence62%helped223 reports · high confidence
Verdict
Mixed
Mostly positive
ResearchDResearch: NoneCResearch: Limited
Meta-analyses / RCTs0 / 00 / 1
Mainly used for
Recovery
% reporting improvement
96% (494)96% (27)
Pain & inflammation
% reporting improvement
86% (485)90% (31)
Skin & hair
% reporting improvement
90% (29)87% (202)
Mood
% reporting improvement
65% (128)86% (7)
Digestion
% reporting improvement
84% (111)100% (4)
Common side effectsfatigue, anhedonia, anxiety, headacheinjection site, redness, stinging, injection pain
Typical dose reportedNot listedNot listed
BPC-157
What a user said
“after 2+ years of nothing working, this is the 1st thing to reverse significant muscle damage ... 40% increase in my range of motion, and nearly the same in muscle strength.”
Full BPC-157 profile →
GHK-Cu
What a user said
“Love it. 44 F. Totally helped even out my skin tone (Irish red cheeks), reduced wrinkles on my forehead and neck, thickened my hair which had been thinning, and grew my eye lashes.”
Full GHK-Cu profile →

Related comparisons

Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate